ImmunoPrecise Antibodies will participate in the 17th Annual Discovery on Target (DOT) being held Boston, MA September 16-19. With over 1,300 attendees and a variety of keynote speakers, training seminars, short courses, roundtables, and networking functions, DOT is said to be the industry’s preeminent event on novel drug target and technologies. Jennifer Bath, Ph.D., and …
ImmunoPrecise Featured Services
B cell Select mAb Discovery
ImmunoPrecise is excited to offer custom B cell Select Antibody Discovery. This proprietary technology allows for selection of target specific B cells from any tissue in a variety of animal species.
Learn More: B cell Select
Our phage display approach is based on building custom immune libraries from multiple species, or the selection of antigen specific recombinant antibody fragments from our proprietary human or llama phage libraries.
Learn More: Phage Display
Coupled with advanced hybridoma technologies, Rapid Prime is ImmunoPrecise’s proprietary immunization protocol, which saves months in development time in combination with our Single-Step semi-solid media selection and clone picking. Positive hybridoma clones are identified just 32 days from project initiation.
Learn More: Hybridoma Development
ImmunoPrecise’s proprietary rabbit monoclonal development allows for the screening of the immune repertoire of the rabbit, creating the power to select the desired antibody directly from the B cells using our B cell Select antibody discovery platform.
Learn More: Rabbit mAbs
At ImmunoPrecise, we offer the following antibody optimization services: antibody chimerization, antibody humanization, and antibody affinity maturation.
Learn More: Antibody Optimization
Our proprietary expression technology is designed to deliver fast and large-scale production of (mammalian) recombinant proteins and antibodies for research and pre-clinical applications.
Learn More: Antibody Manufacturing